Literature DB >> 34169786

Relationship between uric acid and kidney function in adults at risk for tumor lysis syndrome.

Heather P May1, Kristin C Mara2, Erin F Barreto1,3, Nelson Leung4,5, Thomas M Habermann4.   

Abstract

Uric acid drives acute kidney injury in tumor lysis syndrome (TLS). This study investigated the relationship between uric acid and changes in estimated glomerular filtration rate (eGFR) in adults at risk for TLS. Linear regression was used to evaluate the relationship between uric acid area under the curve (AUC) and percent change in eGFR from baseline at hospital dismissal, 1 and 3 months. In 210 included participants, each 100 mg*hour/dL increase in 24 h AUC was associated with an average decline in eGFR at hospital dismissal of 9% (95%CI 3, 15) in univariate analysis. Each 100 mg*hour/dL increase in 24 h AUC was independently associated with an average decline in eGFR of 8% (95%CI 2, 13) at 1 month after dismissal. Additional research is needed to confirm these findings and determine whether treatments that reduce overall uric acid exposure improve kidney outcomes. Preserving kidney health could favorably impact cancer treatment eligibility, tolerability, and outcomes.

Entities:  

Keywords:  Uric acid; acute kidney injury; lymphoma and Hodgkin disease; rasburicase; tumor lysis syndrome

Mesh:

Substances:

Year:  2021        PMID: 34169786      PMCID: PMC8639629          DOI: 10.1080/10428194.2021.1941931

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  36 in total

1.  Impact of early rasburicase on incidence of clinical tumor lysis syndrome in lymphoma.

Authors:  Heather A Personett; Erin F Barreto; Kristen B McCullough; Ross Dierkhising; Nelson Leung; Thomas M Habermann
Journal:  Leuk Lymphoma       Date:  2019-06-21

Review 2.  Uric acid in CKD: has the jury come to the verdict?

Authors:  Barbara Bonino; Giovanna Leoncini; Elisa Russo; Roberto Pontremoli; Francesca Viazzi
Journal:  J Nephrol       Date:  2020-01-13       Impact factor: 3.902

3.  Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.

Authors:  Marian Goicoechea; Soledad Garcia de Vinuesa; Ursula Verdalles; Eduardo Verde; Nicolas Macias; Alba Santos; Ana Pérez de Jose; Santiago Cedeño; Tania Linares; Jose Luño
Journal:  Am J Kidney Dis       Date:  2015-01-13       Impact factor: 8.860

4.  Hyperuricemia and Progression of Chronic Kidney Disease: Role of Phenotype Transition of Renal Tubular and Endothelial Cells.

Authors:  Duk-Hee Kang
Journal:  Contrib Nephrol       Date:  2018-01-23       Impact factor: 1.580

5.  Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease.

Authors:  Markus Sellmayr; Moritz Roman Hernandez Petzsche; Qiuyue Ma; Nils Krüger; Helen Liapis; Andreas Brink; Barbara Lenz; Maria Lucia Angelotti; Viviane Gnemmi; Christoph Kuppe; Hyojin Kim; Eric Moniqué Johannes Bindels; Ferenc Tajti; Julio Saez-Rodriguez; Maciej Lech; Rafael Kramann; Paola Romagnani; Hans-Joachim Anders; Stefanie Steiger
Journal:  J Am Soc Nephrol       Date:  2020-09-16       Impact factor: 10.121

6.  A Clinical and Economic Comparison of Rasburicase and Allopurinol in the Treatment of Patients With Clinical or Laboratory Tumor Lysis Syndrome.

Authors:  Mitchell S Cairo; Stephen Thompson; Krishna Tangirala; Michael T Eaddy
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-11-21

7.  Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy.

Authors:  Elisa Russo; Stefania Drovandi; Gennaro Salvidio; Daniela Verzola; Pasquale Esposito; Giacomo Garibotto; Francesca Viazzi
Journal:  Nutr Metab Cardiovasc Dis       Date:  2020-07-30       Impact factor: 4.222

8.  Uric acid and the prediction models of tumor lysis syndrome in AML.

Authors:  A Ahsan Ejaz; Negiin Pourafshar; Rajesh Mohandas; Bryan A Smallwood; Richard J Johnson; Jack W Hsu
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

9.  Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival.

Authors:  Emmanuel Canet; Lara Zafrani; Jerome Lambert; Catherine Thieblemont; Lionel Galicier; David Schnell; Emmanuel Raffoux; Etienne Lengline; Sylvie Chevret; Michael Darmon; Elie Azoulay
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

10.  Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project.

Authors:  Elisa Russo; Francesca Viazzi; Roberto Pontremoli; Carlo Maria Barbagallo; Michele Bombelli; Edoardo Casiglia; Arrigo Francesco Giuseppe Cicero; Massimo Cirillo; Pietro Cirillo; Giovambattista Desideri; Lanfranco D'Elia; Claudio Ferri; Ferruccio Galletti; Loreto Gesualdo; Cristina Giannattasio; Guido Iaccarino; Giovanna Leoncini; Francesca Mallamaci; Alessandro Maloberti; Stefano Masi; Alessandro Mengozzi; Alberto Mazza; Maria Lorenza Muiesan; Pietro Nazzaro; Paolo Palatini; Gianfranco Parati; Marcello Rattazzi; Giulia Rivasi; Massimo Salvetti; Valérie Tikhonoff; Giuliano Tocci; Andrea Ungar; Paolo Verdecchia; Agostino Virdis; Massimo Volpe; Guido Grassi; Claudio Borghi
Journal:  J Nephrol       Date:  2021-03-23       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.